Related Experiment Video
Updated: May 12, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Aortic stiffness is an independent predictor of stroke in hypertensive patients
Telmo Pereira1, João Maldonado, Liliana Pereira
1Escola Superior de Tecnologia da Saúde de Coimbra - Departamento de Cardiopneumologia1, Coimbra, Portugal. telmopereira@spc.pt
Insights
Aortic Pulse Wave Velocity (PWV) is a significant predictor of stroke in hypertensive patients. Measuring PWV can help identify individuals at higher risk, improving cardiovascular disease management.
Area of Science:
- Cardiology
- Vascular Medicine
- Hypertension Research
Background:
- Cardiovascular disease is a leading cause of death, with risk not fully explained by traditional factors.
- Increased arterial stiffness is a key contributor to cardiovascular morbidity and mortality.
Purpose of the Study:
- To determine if Aortic Pulse Wave Velocity (PWV) predicts stroke occurrence in hypertensive patients.
- To evaluate PWV as a prognostic marker beyond established cardiovascular risk factors.
Main Methods:
- A prospective, observational cohort study included 1133 hypertensive patients.
- Aortic Pulse Wave Velocity (PWV) was measured using the Complior method.
- Detailed clinical evaluations and blood pressure measurements were performed.
Main Results:
- Hypertensive patients with increased PWV had a 4.15 times higher risk of stroke compared to those with normal PWV.
- PWV independently predicted stroke in multivariate analysis (HR=1.40 per 1m/s increment), even after adjusting for classical risk factors.
- Including PWV in risk models significantly improved stroke prediction (Harrell's C increased from 0.68 to 0.71).
Conclusions:
- Aortic PWV is an independent risk factor for stroke in hypertensive individuals.
- Integrating PWV measurement into clinical follow-up is strongly recommended for managing cardiovascular risk.
Background:
Cardiovascular disease remains the leading cause of death in developed countries and is not entirely predicted by classic risk factors. Increased arterial stiffness is an important determinant of cardiovascular morbidity and mortality.
Objective:
To assess whether Aortic Pulse Wave Velocity (PWV) predicts the occurrence of stroke in hypertensive patients
Methods:
A cohort, observational and prospective study, including 1133 hypertensive patients (586 men), with a mean age 51.05 ± 12.64 years, was designed. PWV with the Complior method was performed in all patients, as well as a detailed clinical evaluation and blood pressure measurement.
Results:
The cumulative incidence of stroke in hypertensive patients with increased PWV was 3.25% (CI: 1.97% -5.25%), compared with 0.78% (CI: 0.28% -1.87%) in hypertensive patients with normal PWV (Risk Ratio (RR) =4.15; CI:1.53-11.26). In a multivariate analysis, adjusting the model to classical cardiovascular risk factors, PWV was an independent predictor of stroke, with a Hazard Ratio (HR) = 1.40 (CI:1.13-1.73, p<0.001), indicating a 40% increase in the risk of stroke per 1m/s increment in PWV. The addition of PWV to a model consisting of conventional cardiovascular risk factors significantly improved the discriminative capacity for stroke (Harrell's C increased from 0.68 to 0.71 after the inclusion of the PWV; p<0.01).
Conclusion:
Aortic PWV is a risk factor for stroke in hypertensive patients, and its integration into clinical follow-up programs in patients whose cardiovascular risk is manifest is strongly recommended.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
